Table 2 Patents on CUR for the treatment of PCOS
Sl no | Patent no | Title | Description | Reference |
|---|---|---|---|---|
1 | CN116687931B | Medicine for treating PCOS and application thereof | Concomitant administration of CUR and sinomenine normalized irregular estrous cycle in DHEA induced PCOS rats. The combination also improved insulin resistance | [71] |
2 | CA3213258 A1 | Compositions for management of PCOS | The combination of bidsemothycurcumin (20–80%w/w), demethoxycurcumin (10–35%w/w), and CUR (30–50%w/w) decreased elevated body weight, ovary weight, thyroid stimulating hormone, serum testosterone, and glucose in letrozole induced PCOS mice. It also reduced oxidative stress, insulin resistance, hyperglycemia, hyperlipidemia, and gut dysbiosis | [72] |